SRP0570
5′-NUCLEOTIDASE/CD73, His-Tag
recombinant, expressed in HEK 293 cells
Synonym(s):
5′- nucleotidase, Ecto-5′-nucleotidase
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.26
UNSPSC Code:
12352202
Product Name
5′-NUCLEOTIDASE/CD73, His-Tag, recombinant, expressed in HEK 293 cells
recombinant
expressed in HEK 293 cells
form
frozen liquid
mol wt
58.6 kDa
UniProt accession no.
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... NT5E(4907)
Application
5′-Nucleotidase/CD73 has been used as a standard in recombinanthuman CD73 assay.
Biochem/physiol Actions
5′-Nucleotidase/CD73 actsas a rate-limiting enzyme to produce adenosine. It helps in upholding tissuehomeostasis by converting the adenosine triphosphate (ATP)-triggered immuneactivation to adenosine-mediated immunosuppression.CD73 is a novel immunoinhibitory protein that participates in tumor growthand metastasis. CD73 in combination with conventional therapy and/or otherimmune checkpoint inhibitors has been reported to show therapeutic effectsagainst cancer.
General description
5′-Nucleotidase/CD73 is glycosyl-phosphatidyl inositol (GPI)- anchored cell surface protein. Itis present in various tissues and cells including endothelial cells, epithelialcells, and subsets of B and T cells.
Physical form
Aqueous solution
signalword
Warning
hcodes
pcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Targeting CD73 to augment cancer immunotherapy
Meejeon Roh, et al.
Current Opinion in Psychiatry, 53, 66-76 (2020)
Amanda de Fraga Dias et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 162, 105823-105823 (2021-03-31)
Glioblastoma (GBM) is the most frequent and aggressive brain tumor in adults and the current treatments only have a modest effect on patient survival. Recent studies show that bozepinib (BZP), a purine derivative, has potential applications in cancer treatment. The
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service